Aerobic Training in Metastatic Breast Cancer

NCT01725633 | Completed

• 1 other identifier: MSKCC 14-170
• Study Type: interventional
• Target: 27
• Locations: 1 country
• Sites: 2

Brief Summary

This study is being done to examine the safety and feasibility of a supervised progressive exercise program in women diagnosed with metastatic breast cancer. Previous research among women with metastatic breast cancer has shown that some of the treatments commonly used in this population may have an adverse impact on physical fitness levels leading to feelings of fatigue and poor quality of life. Supervised exercise training has been shown to reduce some of these side-effects in women with early-stage breast cancer receiving common cancer treatments. However, it is not known if supervised exercise training is a safe and feasible intervention in women with metastatic breast cancer. This study is designed to find out if supervised exercise training is safe as the patients undergo treatments for metastatic breast cancer.

Conditions

Metastatic Breast Cancer

Keywords

Stretching; Nonlinear Aerobic Training; 14-170

Outcome Measures

Primary Outcomes (1)

• safety of aerobic training

  Safety will be evaluated by the type and prevalence of adverse events during study-related assessments as well as aerobic training and progressive stretching sessions. The NCI Common Terminology Criteria for Adverse Events Version 4.0 (NCI-CTCAE) will be used to grade toxicities during the trial.

  2 years

Secondary Outcomes (1)

• feasibility of aerobic training

  2 years

Study Arms (2)

Progressive Stretching Group

OTHER

Behavioral: Progressive Stretching Group; Other: Blood draw

Nonlinear Aerobic Training

EXPERIMENTAL

Behavioral: Nonlinear Aerobic Training; Other: Blood draw; Other: Cardiopulmonary Exercise Testing (CPET)

Interventions

Progressive Stretching Group BEHAVIORAL

Participants assigned to the progressive stretching group will be provided with a progressive stretching program that matches the aerobic training interventions in terms of program length (16 weeks), social interaction (all sessions will be supervised), and session duration (20-45 minutes/session, ± 10 minutes).

Progressive Stretching Group

Nonlinear Aerobic Training BEHAVIORAL

Participants assigned to the nonlinear aerobic training arm will perform no more than 150 minutes per week of structured supervised aerobic training as part of clinical trial participation. Exercise performed outside the structured sessions (i.e., contamination) will be assessed via self-report of exercise behavior using the Godin-Leisure Time Exercise Questionnaire (GLTEQ). For ethical reasons, we will not instruct participants not to exercise outside the structured sessions, but we we will encourage participants to maintain their level of exercise behavior prior to study initiation.

Nonlinear Aerobic Training

Blood draw OTHER

At Weeks 4, and 8, all participants will have a complete blood count (CBC) test performed.

Nonlinear Aerobic Training; Progressive Stretching Group

Cardiopulmonary Exercise Testing (CPET) OTHER

At the end of Week 6, participants repeat the CPET in the nonlinear aerobic training group.

Nonlinear Aerobic Training

Eligibility Criteria

• Age: 21 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• MSK histologically confirmed metastatic breast cancer
• Measurable disease (or nonmeasurable bone-only disease) assessed by CT or PET/CT performed as part of standard of care, at the discretion of the attending oncologist in the Breast Medicine Service
• ≥18 years of age;
• Life expectancy \>3 months;
• ECOG ≤ 1
• Sedentary, as per the leisure score index (LSI) of the Godin Leisure-Time Exercise Questionnaire (GLTEQ) . Participants who perform regular moderate or vigorous intensity exercise at least 5 days/week, for at least 30 minutes/session, are not eligible
• Able to achieve an acceptable peak baseline CPET, as defined by any of the following criteria:
• Achieving a plateau in oxygen consumption, concurrent with an increase in power output;
• A respiratory exchange ratio ≥ 1.10;
• Attainment of maximal predicted heart rate (HRmax) (i.e., within 10 bpm of age-predicted HRmax \[HRmax = 220-Age\[years\]);
• Volitional exhaustion, as measured by a rating of perceived exertion (RPE) ≥ 18 on the BORG scale
• Normal cardiac function (left ventricular ejection fraction ≥50%);
• Medical clearance from attending oncologist indicating no relative contraindications to undergo a symptom-limited cardiopulmonary exercise test and aerobic training intervention;
• Patients with "treated and stable" brain lesions of a duration of ≥ 2 months may be enrolled
• Willing to be randomized to one of the study arms

You may not qualify if:

• Any of the following absolute contraindications to cardiopulmonary exercise testing:
• Acute myocardial infarction within 3-5 days of any planned study procedures
• Unstable angina
• Uncontrolled arrhythmia causing symptoms or hemodynamic compromise;
• Recurrent syncope
• Active endocarditis;
• Acute myocarditis or pericarditis
• Symptomatic severe aortic stenosis
• Uncontrolled heart failure
• Acute pulmonary embolus or pulmonary infarction within 3 months of any planned study procedures
• Thrombosis of lower extremities
• Suspected dissecting aneurysm
• Uncontrolled asthma
• Pulmonary edema
• Room air desaturation at rest ≤ 85%

Sponsors & Collaborators

• Memorial Sloan Kettering Cancer Center: lead
• Duke University: collaborator

Study Sites (2)

Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States

Location

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

Related Publications (2)

• Novo RT, Thomas SM, Khouri MG, Alenezi F, Herndon JE 2nd, Michalski M, Collins K, Nilsen T, Edvardsen E, Jones LW, Scott JM. Machine Learning-Driven Phenogrouping and Cardiorespiratory Fitness Response in Metastatic Breast Cancer. JCO Clin Cancer Inform. 2024 Sep;8:e2400031. doi: 10.1200/CCI.24.00031.

  PMID: 39270146 DERIVED

• Scott JM, Iyengar NM, Nilsen TS, Michalski M, Thomas SM, Herndon J 2nd, Sasso J, Yu A, Chandarlapaty S, Dang CT, Comen EA, Dickler MN, Peppercorn JM, Jones LW. Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: A randomized controlled trial. Cancer. 2018 Jun 15;124(12):2552-2560. doi: 10.1002/cncr.31368. Epub 2018 Apr 6.

  PMID: 29624641 DERIVED

Related Links

• Memorial Sloan Kettering Cancer Center

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Blood Specimen Collection; Exercise Test

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Specimen Handling; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Punctures; Surgical Procedures, Operative; Investigative Techniques; Heart Function Tests; Diagnostic Techniques, Cardiovascular; Respiratory Function Tests; Diagnostic Techniques, Respiratory System; Ergometry

Study Officials

• Lee Jones, PhD

  Memorial Sloan Kettering Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 28, 2011
• First Posted: November 14, 2012
• Study Start: December 1, 2010
• Primary Completion: April 4, 2023
• Study Completion: April 4, 2023
• Last Updated: April 6, 2023

Record last verified: 2023-04

Locations

US (2)